← Search & browse all drugs
ALIMENTARY TRACT AND METABOLISM › ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS › INTESTINAL ANTIINFECTIVES › Antibiotics
paromomycin
A07AA06
Adult Dosing
- Intestinal amebiasis: 25-35 mg/kg/day divided in 3 doses with meals for 7 days
- Hepatic encephalopathy: 4 g/day divided in 3 to 4 doses for 5 to 6 days
- Visceral leishmaniasis (off-label): 11-15 mg/kg/day intramuscularly for 14-21 days
- Cryptosporidiosis in HIV (off-label): 500 mg to 2 g daily in divided doses for 14-28 days
Pediatric Dosing
- Intestinal amebiasis: 25-35 mg/kg/day divided in 3 doses with meals for 7 days
- Hepatic encephalopathy: Safety and efficacy not established in children
- Visceral leishmaniasis (off-label): 15 mg/kg/day intramuscularly for 21 days
Indications
- Treatment of acute and chronic intestinal amebiasis
- Management of hepatic encephalopathy as adjunctive therapy
- Off-label: Treatment of visceral leishmaniasis, cryptosporidiosis, and Dientamoeba fragilis infections
Mechanism of Action
- Aminoglycoside antibiotic that binds directly to 16S ribosomal RNA
- Inhibits protein synthesis and causes misreading of the genetic code in susceptible protozoa and bacteria
- Poorly absorbed from the gastrointestinal tract, exerting a primarily local luminal anti-amebic effect
Contraindications
- Hypersensitivity to paromomycin or other aminoglycosides
- Presence of intestinal obstruction or ulceration due to risk of increased systemic absorption
Adverse Reactions
- Gastrointestinal: Nausea, vomiting, abdominal cramps, diarrhea, steatorrhea
- Nervous system: Headache, dizziness, vertigo
- Renal: Nephrotoxicity (rare, primarily with systemic administration or severe GI ulceration)
- Hypersensitivity: Rash, urticaria, pruritus
Drug Interactions
- Oral anticoagulants: May enhance the anticoagulant effect of vitamin K antagonists by reducing vitamin K-producing gut flora
- Digoxin: May decrease oral absorption and serum concentrations of digoxin
- Systemic aminoglycosides: Concurrent use increases the risk of additive toxicity, including ototoxicity and nephrotoxicity if significant absorption occurs
Curated Content: Needs Vetting Before Put to Clinical Use